Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 468637
                    [Title] => GSK launches new allergic rhinitis treatment
                    [Summary] => 
MANILA, Philippines – GlaxoSmithKline (GSK) recently announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).
                    [DatePublished] => 2009-05-19 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 464587
                    [Title] => GSK launches new treatment for allergic rhinitis
                    [Summary] => 
MANILA, Philippines – GlaxoSmithKline (GSK) has announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

FLUTICASONE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 468637
                    [Title] => GSK launches new allergic rhinitis treatment
                    [Summary] => 
MANILA, Philippines – GlaxoSmithKline (GSK) recently announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).
                    [DatePublished] => 2009-05-19 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 464587
                    [Title] => GSK launches new treatment for allergic rhinitis
                    [Summary] => 
MANILA, Philippines – GlaxoSmithKline (GSK) has announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

GSK launches new allergic rhinitis treatment

May 19, 2009 - 12:00am

MANILA, Philippines – GlaxoSmithKline (GSK) recently announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).

Health And Family

GSK launches new treatment for allergic rhinitis

May 7, 2009 - 12:00am

MANILA, Philippines – GlaxoSmithKline (GSK) has announced the availability in the Philippines of its new intranasal steroid (INS) fluticasone furoate for the treatment of allergic rhinitis (AR).

Science and Environment